Appia Bio to Present Data on API-192 at the 65th American Society for Hematology Annual Meeting and Exposition

/PRNewswire/ -- Appia Bio, Inc., a biotechnology company developing allogeneic chimeric antigen receptor (CAR)-engineered invariant natural killer T (CAR-NKT)...

Related Keywords

San Diego Convention Center ,California ,United States ,San Diego ,American ,Appia Bio ,Gilead Company ,San Diego Convention Center Halls ,Prnewswire Appia Bio Inc ,American Society Of Hematology ,American Society ,Annual Meeting ,Cord Blood ,Lanny Gov ,Appia Cells Utilized ,Health Care Amp Hospitals ,Biotechnology ,Trade Show News ,Clinical Trials Amp Medical Discoveries ,